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The year 2010 was the 350th anniversary of the founda-
tion of the Royal Society of London, the world’s oldest
scientific academy. Among its earliest correspondents
was the Dutch instrument maker, Anton van Leuwen-
hoek, whose single lens microscopes opened the eyes of
the world to what had previously been invisible. In that
same era of scientific and philosophical advance, the
Enlightenment, attention was first drawn to the problem
of industrial pollution by John Evelyn’s petition, Fumifu-
gium, to King Charles II in 1661. However, it was not
until late in the Industrial Revolution, and the rise in
use of coal as a source of power in factories and heating
in homes, that the full impact of particulate pollution
began to be recognised. Pollution episodes in Donora,
Pennsylvania and the Meuse valley in Belgium in the
1940s, and the great London smog of 1952, were asso-
ciated with dramatic increases in deaths in the local
populations and led eventually to Western Governments
taking action to curb emissions. Nevertheless, coal
remained the primary cause of urban pollution into the
1970s, when oil began to take over.
Early days
My first conscious meeting with particles was in the
1940s as a child in Liverpool and Leeds, two heavily pol-
luted UK cities where cold, still winter days were char-
acterised by dense smogs that prevented one seeing
across the street. In the former city during the early
part of the 2nd World War, matters were temporarily
worsened by the generation of smoke screens across the
city to obscure it from the bombers of the Luftwaffe,
the coal ovens being sited across the street from my
parents’ apartment. It was an ineffective measure and
the bombs continued to fall! As a medical student in the
1950s I became aware of the fact that these smogs were
associated with large numbers of excess deaths, and
every winter the hospital wards in that era filled with
patients in respiratory failure; smoking was almost uni-
versal in adults and chronic bronchitis was known then
as the English Disease, fully justifying King James VI of
Scotland’s famous Counterblast to Tobacco of 1604; “A
custom loathsome to the eye, hateful to the nose, danger-
ous to the lungs...” But so often a pollution episode pro-
vided the coup de grâce. Public health measures, in the
UK the Clean Air Acts, gradually reduced this black
smoke pollution and in Western Europe the effects
became much less obvious - we began to believe that
urban air pollution was no longer a problem, especially
as it was much less easy to see, and the haziness of the
air in large cities began to be accepted as normal. The
pollution not only had been reduced but also, subtly, it
had started to change colour. What had been measured
as British Black Smoke, a relatively crude but useful col-
orimetric method, was now measured as PM10 or PM2.5,
particulate matter less than 10 or 2.5 micrometers in
aerodynamic diameter. By one of those ironies that are
so familiar in academic life, the pioneering air pollution
research unit at St Bartholomew’s Hospital Medical
School in London, which had made huge inroads into
understanding and quantifying pollution under Prof
Patrick Lawther, closed just as the new evidence from
major US epidemiological studies of pollution began to
be published.
My next meeting with particles was as a young doctor.
In 1964 I spent a year working in Stoke on Trent, site of
the famous Wedgewood pottery industry, and here I saw
both men and women suffering from silicosis from
exposure to quartz used in glazes and for bedding por-
celain in the kilns. I learned of the efforts made to pro-
tect these workers and the studies that had shown the
highest exposures often to have come from changing
their clothes at the end of a shift. I learned that the dis-
ease had been known and understood pathologically
since the late 18th century, yet was still occurring and
was untreatable - unsuccessful attempts had been made
to ameliorate its effects by inhaling aluminium oxide
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powder, on the theoretical understanding that the sur-
face of the quartz crystal became less toxic if it were
coated with other minerals. I was interested to find that
the pottery industry was sited in Stoke because of the
local availability of coal, the china clay (kaolin) being
brought there from Cornwall in the south west of Eng-
land, initially by canal then by rail, and I also saw my
first patients with coal worker’s pneumoconiosis in that
year. An interest in industrial medicine and in the pre-
vention of industrial disease was born and, after some
further forays into cardiology and neurology, I found
myself researching pneumoconioses as a chest physician
in West Virginia, USA in 1969.
West Virginia, Cardiff, coal and Aspergillus
In the early 20th century West Virginia had been the
scene of coal mine wars, when owners had fought the
unions, quite literally, bringing non-unionised labour
mostly from Eastern Europe, in trains equipped with
armour plating and machine guns, to work in the
mountain mines of the State. An uneasy truce existed
when I was there, but still there were tensions, notably
with respect to compensation for pneumoconiosis. A
broadly sympathetic Federal Government had enacted a
compensation law, the Black Lung Act, and doctors
were cast in the role of deciding who should and should
not get the money. Often, scientific evidence took sec-
ond place to political judgement in making these deci-
sions and I worked in a unit that was charged with
accruing the evidence. The main issue was this; smoking
causes chronic obstructive pulmonary disease (COPD),
most miners smoked and many get COPD, coal causes
pneumoconiosis but pneumoconiosis is not clearly asso-
ciated with COPD. In many miners the two diseases
coexist, but does coal dust per se cause COPD? Some of
our preliminary studies suggested that it did [1,2], but
there was a lot of opposition to the idea, based on mis-
leading epidemiology. No-one had at that time pub-
lished data containing estimates of exposure to coal
dust, but this was very shortly to change. In 1970 the
Edinburgh Institute of Occupational Medicine (IOM)
published a landmark paper in Nature on the associa-
tion between coal dust exposure and risk of pneumoco-
niosis, based on careful measurements and estimates of
dust exposure on some 30,000 miners [3].
At that time I was contemplating returning to the UK
to work in the NHS as a full-time chest physician, and
within a year I had obtained a post in Cardiff, South
Wales, close to Britain’s biggest coal mining area. The
MRC pneumoconiosis unit there was then mainly inter-
ested in asbestos, Chris Wagner having arrived a year or
two before from South Africa where he had described
the association of mesothelioma with crocidolite expo-
sure [4], but the unit’s reputation was founded on the
work it had done under John Gilson on standardisation
of radiology and lung function for epidemiology in coal
mining. It had never, however, investigated exposure
assessment and had thus missed the opportunity which
had been taken by the UK National Coal Board to inves-
tigate exposure-response relationships. My contact with
the unit was limited, my main role at this stage being in
the clinical management of asthma, though my interest
in occupational disease led to me co-authoring a book
on the subject with my US colleague, Keith Morgan [5].
For a few years my research interest was captured by
another sort of particle altogether, Aspergillus fumigatus
[6,7]. This common fungus lives in the soil on dead
organic matter and its tiny spores, c3 μm in diameter,
are responsible for an impressive number of human and
animal respiratory diseases, unlike any other airborne
fungus. What was it about this organism that conferred
such pathogenicity? A series of studies later showed it
had the power to resist phagocytosis by macrophages
and indeed was able to turn the tables on phagocytes by
immobilising them and using them as a food source [8].
This was clearly an advantage to survival from phagocy-
tosis in the soil by competing organisms, and its patho-
genicity was irrelevant to its life history, as it had never
relied on colonisation of lungs to reproduce - a chance
consequence of its need to survive in the soil.
Edinburgh and the Institute of Occupational
Medicine
This interlude of study of microbial particles proved
inconclusive as we were never able to identify the che-
mical released from the spore surface that had this
remarkable paralytic effect on motile cells, and to my
knowledge this remains unsolved to this day. The stu-
dies overlapped my move in 1977 from Wales to Scot-
land and the Institute of Occupational Medicine; a
return to mineral particles, since IOM had been
founded in 1969 as a charitable research institute by the
National Coal Board to research mining diseases.
In 1977, when I arrived, the work of the Institute was
centred on coal and asbestos diseases. The coal research
led by Michael Jacobsen was based on an epidemiologi-
cal programme known as the Pneumoconiosis Field
Research (PFR). Having first described the association
between pneumoconiosis and respirable dust exposure,
its emphasis was on refining these complex relations
(how much and what kinds of dust cause pneumoconio-
sis?) and on the question raised above, does coal dust
cause chronic obstructive lung disease? The key to the
success of this research was the multi-disciplinary nat-
ure of the scientific effort - epidemiologists worked clo-
sely with physicians, physiologists, occupational
hygienists, physicists, biologists and pathologists. The
essential contribution had come from the physicists who
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asked the question: how can we measure the fraction of
particles that reaches that part of the lung, the acinus,
where pneumoconiosis develops? The answer was the
invention by two physicists, Henry Walton and Bill
Hamilton, of the MRE 114A respirable dust sampler,
which was used in all the research as well as generally
in coal mines to monitor dust levels [9]. This allowed
quantification of the exposures of the miners to particles
less than c7 μm aerodynamic diameter and estimation of
the relationships between these and their risks of radi-
ological change, functional impairment, pathological
changes in the lung and mortality. It also allowed esti-
mation of the effects of quartz in contributing to their
health risks. Central to the work on lung pathology
were John Davis and Anne Ruckley, who were finally
able to show a clear relationship between coal dust
exposure and pathological emphysema [10], a finding
crucial to obtaining recognition that this disease (and
the consequent COPD) was in fact a risk not only of
smoking but also of coal dust exposure. This finding
coincided with work led by Bill Marine which demon-
strated the relationship of coal dust exposure with
decrements in lung function consistent with obstructive
lung disease [11].
This productive period from 1977 to 1990 also saw
the IOM study a number of other particle exposures in
a similar manner, all leading to the promulgation of UK
and, in one case USA, Dust Standards. These were the
wool industry, polyvinyl chloride production and the, by
then defunct in UK, oil shale industry [12-14]. In all
three cases relationships between exposure to the rele-
vant dust and lung disease were demonstrated for the
first time, something that makes me wonder how many
other dusty industries are associated with damage to the
lungs that has not yet been demonstrated. An old col-
league used to say “the normal human is the one who
has not yet been fully investigated!” There is some truth
in this with respect to dusty trades also. The shale stu-
dies were of particular relevance to the possible increase
in the use of shale deposits as a future source of oil, in
view of the political instability of the major sources of
this commodity.
As a chest physician I had witnessed the rise in lung
cancer associated with smoking (the association was
first described by Richard Doll when I was a student),
and in my later years it was very satisfying to see a
decline in this disease in men, though unfortunately it
has now become the most common cancer in women as
our relative smoking habits have changed. I saw my first
patient with mesothelioma, an incurable malignant dis-
ease of the pleura, in 1971 at which time it was a very
uncommon disease. By the time I retired in 2003 it was
the cause of more than 2000 deaths annually in UK and
I saw a patient with it almost every week. The cause
was of course the increased exposure of workers to
asbestos, especially amphiboles, from the 1930s onwards
until about 1980 [15]. Sadly, this epidemic will continue
for at least another decade. During my time in Cardiff I
got to know Chris Wagner well and when I arrived in
Edinburgh I found John Davis to be pursuing the same
line of research. Although the cause was known, it was
essential to prevention, as long as asbestos was used, to
understand the mechanisms, and this acquainted me
with particle toxicology. Again the IOM had the great
advantage of having skilled physicists under Jim Vincent
who could generate and measure dust clouds, toxicolo-
gists led by Ken Donaldson who could measure effects
in vivo and in vitro, and epidemiologists including Brian
Miller and Fintan Hurley who in helping to plan and
analyse studies could make sure that all their conclu-
sions were valid. It might be thought that the asbestos
issue could have been solved simply by banning the
material, but this does not take account of the exposures
likely to occur when asbestos already in place is
removed or disturbed. Nor does it take account of the
need of industry for durable fibres which might have the
potential to cause similar effects on the health of work-
ers. This programme of work led to the validation of the
important paradigm of fibre toxicity, showing much of
the toxicity of fibres to lie in their length, diameter and
durability in tissue [16]. This research also contributed
to understanding that the durability of the fibres was
critical to the causation of mesothelioma, explaining
why the least durable, chrysotile, was a less potent cause
than the amphibole types. Alongside this work, the IOM
physicists designed an eyepiece microscope graticule
incorporated in fibre counting rules for a UK Asbestos
standard [17], and set up national and international
quality control schemes for fibre counting.
By the late 1980s the nationalised UK coal industry
was in decline and British Coal attempted to close the
IOM, which by then had established a strong interna-
tional reputation. After a considerable struggle, it proved
possible to set it up in 1990 as an independent self-
funding charity. It is particularly pleasing to see that it
continues as a strong research institute to this day. The
original key to the IOM’s survival was persuading British
Coal to make a one-off grant and by obtaining generous
short-term research funding from the man-made fibre
industry and the Colt Foundation. These grants,
together with the retiral from IOM of the most senior
staff provided the launch pad for its subsequent success
under Colin Soutar’s and now Phil Woodhead’s
leadership.
Aberdeen, asthma and air pollution
I had the good fortune to obtain a part-time post in
Aberdeen University in 1988 and this gave me the
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opportunity to move there when the IOM closed in
1990. I was also asked to chair the UK Government’s
Expert Panel on Air Quality Standards (EPAQS), in
spite of having next to no expertise in the subject. But a
move of job in one’s 50s is stimulating and gives rise to
new ideas. At Aberdeen I was freed from the burden of
running a large research institute but faced with the dif-
ferent burden of starting my own research from scratch.
I reverted to my clinical persona, and asked why asthma
had increased so much during my professional lifetime.
This was clearly an environmental effect and the smart
money was on pollution or biological particles, even
though neither had increased. A rather fanciful theory
based on illogical grounds held that it was something to
do with lack of infection or over-cleanliness. I felt that
none of these was plausible and in any case held little
prospect of leading to preventive action, so my collea-
gues and I proposed that although attacks of asthma
may be provoked by inhaled biological or air pollution
particles, the cause of the rise was likely to be a conse-
quence of increased population susceptibility, perhaps
from the rather dramatic changes in diet I had noticed
in my lifetime [18]. I’m afraid that this idea was received
with a deafening silence and it was obviously difficult to
obtain research funding. However, we persevered and a
programme of research into the effect of vitamin intake
by the mother during pregnancy has now produced suf-
ficient evidence of effects of vitamins D and E on early
airway development for it to continue under my succes-
sor, Graham Devereux, some 20 years later [19,20].
Happily, our epidemiological results have now received
support from similar studies in USA [21,22]. A broad
lesson from this is that changes in the prevalence of dis-
ease must be environmental but susceptibility may
change as well as the environment; susceptibility was
always thought to be largely genetic but this is not so.
Not only may genes be turned on or off by environmen-
tal factors such as infections or nutrition, but also the
target tissue may be made more or less susceptible in
the same way. Thinking laterally is very desirable in
research. Equally important is finding the right collea-
gues and this work relied very much on the expertise of
Graham Devereux, Geraldine McNeill, and a number of
excellent PhD students. I hope that it will soon be possi-
ble to give pregnant women science-based advice on the
best diet to reduce the risk of asthma in their offspring.
The work of EPAQS was another example of multidis-
ciplinary collaboration, as the Panel included epidemiol-
ogists, clinicians, meteorologists and experts in
environmental measurement. In the 10 years I chaired it
we recommended science-based standards for nine pol-
lutants, including particles. Among the early members
was Robert Waller who had been one of the original
members of the St Bartholomew’s unit. He had made
measurements of pollution in the old days of smog and
was healthily sceptical of the findings of the more recent
epidemiology. The concentrations of particles were so
low compared to those in the 1950s that it seemed
implausible that they could cause effects such as death
from heart attack. He and others thought that there was
a hidden confounder, probably related to inability to
account adequately for temperature in the statistical
models. The argument was that it was very unlikely that
the inhalation of around a milligram of carbon over 24
hours could kill people, and I have to say that I agreed.
Yet the epidemiology did indeed suggest strongly and
consistently that this was the case [23,24]. Air pollution
suddenly seemed interesting! A plausible explanation
was necessary, one that could be tested experimentally,
and it came to me by serendipity.
Following one such discussion of plausibility I went
home and picked up the latest Lancet, which contained
a paper on seasonal changes in fibrinogen levels in peo-
ple’s blood [25]. No explanation was offered other than
possible infections, which were known to cause rises in
fibrinogen. Fibrinogen is involved in the cascade of che-
mical changes that lead to blood clotting and blood clot-
ting is known to be a factor in heart attacks (once called
coronary thrombosis). Eureka! Maybe inflammation in
the lungs caused by particles could induce rises in fibri-
nogen sufficient to increase the risk of a heart attack in
susceptible people? But still there was the problem of
the tiny dose of particles associated with this effect. I
recalled the pioneering studies of Gunther Oberdörster
and colleagues in which they had shown the different
effects of ultrafine particles of titanium dioxide com-
pared to larger particles of the same material [26] and I
was aware of work dating back to the 1960s in London
which had shown the huge numbers of such particles in
air pollution [27]. Could it be that, not the mass, but
the number of particles, mostly very small and capable
of penetrating the respiratory epithelium, triggered
interstitial inflammation and subsequent changes in
blood clotting? My colleagues Ken Donaldson, Bill Mac-
Nee and David Godden and I wrote our hypothesis
paper and it was published in the Lancet later that year,
1995 [28]. I think it is fair to say it changed the way
scientists thought about and investigated air pollution
and the effects of particles.
Nanoparticles
Fundamental to the Lancet paper was the understanding
from Oberdörster’s group that what we then called
ultrafine particles behaved differently in the lung to lar-
ger particles of the same material, having the ability to
cross cell and tissue barriers and to cause greater
inflammatory responses. Air pollution epidemiological
research revealed that particle rises were associated with
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increases in markers of inflammation and toxicological
studies showed mechanisms consistent with the hypoth-
esis [29]. It is becoming apparent that particle numbers,
which reflect best the ultrafines, may be associated with
cardiac effects whereas particle mass is more clearly
associated with respiratory end points [30], which is
what one would expect since the larger particles which
contribute more to mass are deposited on the airways
[31]. The mechanisms of action of ultrafine particles on
the heart are still the subject of active investigation, but
my hunch is that they influence inflammation, endothe-
lial stickiness and fibrinogen activation [32], a threefold
attack on coagulation. In this they would be acting
rather like bacterial infections.
The final part of the story came in 2003 when I was
asked to join a working group of the Royal Society and
Royal Academy of Engineering on nanoscience and
nanotechnology. I learned something of these new and
potentially disruptive technologies and my role was to
attempt to foresee any possible health hazards that
might arise in their development and applications. We
considered not only direct hazards to human health but
also hazards that might arise from environmental dis-
ruption. In our report we concentrated on two main
issues - one arising from our understanding of particu-
late air pollution and the other from experience with
asbestos. We understood there to be many applications
of nanotechnologies that promised only benefits to
society but that, in the area of the manufacture and use
of nanoparticles there were foreseeable hazards [33].
First, if individuals were exposed in the air or on the
skin to large numbers of nanoparticles they might have
effects, through absorption, on distant organs as well as
on the one to which they were applied. For example,
inhalation might affect the heart or the brain, the latter
possibly through neural transmission along the olfactory
nerve. These possible effects would of course depend on
dose but also on the surface properties of the particle,
which could even be engineered to be beneficial. Sec-
ondly, particles shaped like asbestos, if persistent in tis-
sue and of appropriate length, could cause the same
effects as that mineral. There is a fundamental differ-
ence to classical concepts of toxicology here. Usually we
think of effects being a consequence of dose to the tar-
get organ, but with nanoparticles we have also to think
in terms of effects on target cells or organs causing sec-
ondary effects on other organs. This point has not yet
been grasped by everyone working in the field. Our
report proved influential, and it is probably reasonable
to say that it initiated the current interest in nanotoxi-
cology [34,35].
Conclusions
Over 50 years I have learnt many things, of which the
most important are:
Scientists gain much by working in a multi-disciplin-
ary environment;
Science progresses mainly by lateral leaps in thinking,
often provoked by chance reading or sceptical question-
ing of accepted wisdom;
Medicine is no more nor less than human ecology,
and humans (and their genomes) have been shaped by
evolution in their own particular environments;
Toxicology and epidemiology are indispensible part-
ners in understanding the causation of disease, and
many research opportunities exist in the interface of the
two.
Everything is made of particles and the study of parti-
cles is interesting!
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